Pharmerit (United States)
Dados da instituição
| Tipo | COMPANY (active) |
|---|---|
| País | Bethesda, US |
| Trabalhos | 9 |
| Pesquisadores | 11 |
| Citações | 1 |
| Índice h | 1 |
| Cobertura | 2014 - 2024 |
| ROR | 040d4nb67 |
| GRID | grid.482835.0 |
| OpenAlex | I4210134090 |
| Site | https://www.pharmerit.com |
| Também conhecida como | Pharmerit (United States) |
Administering selected subscales of patient-reported outcome questionnaires to reduce patient burden and increase relevance
Dimensionality and validity of the content knowledge for teaching construct using cognitive diagnostic modeling and known groups comparisons
Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma
Validation of the Ankylosing Spondylitis Quality of Life assessment tool in patients with non-radiographic axial spondyloarthritis
Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder
Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma
Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO
Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO
Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma
A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder
Validation of the Ankylosing Spondylitis Quality of Life assessment tool in patients with non-radiographic axial spondyloarthritis
Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma
Dimensionality and validity of the content knowledge for teaching construct using cognitive diagnostic modeling and known groups comparisons
Administering selected subscales of patient-reported outcome questionnaires to reduce patient burden and increase relevance
| ARTICLE | 9 |
|---|
| 2024 | 1 |
|---|---|
| 2022 | 1 |
| 2021 | 2 |
| 2020 | 2 |
| 2019 | 1 |
| 2018 | 1 |
| 2014 | 1 |